BIAFVSNXTC• 6 Months (Normalized)
BIAF vs NXTC (bioAffinity Technologies Inc. vs NextCure Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
-72.25%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
NXTC Performance $7
-41.47%
NextCure Inc.
Normalized Baseline0.00%
Alpha Spread Margin NXTC LEADS
-30.78%
NXTC outperforming by 30.78%
BIAFNXTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF NXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BIAF Price | BIAF Gain (%) | NXTC Price | NXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | -72.25% | $7.00 | -41.47% | -30.78% |
| Sep 10, 2026 | $9.39 | -67.23% | $7.31 | -38.88% | -28.35% |
| Sep 09, 2026 | $10.50 | -63.35% | $8.07 | -32.53% | -30.82% |
| Sep 08, 2026 | $8.93 | -68.83% | $8.42 | -29.60% | -39.23% |
| Sep 04, 2026 | $15.27 | -46.70% | $7.82 | -34.62% | -12.08% |
| Sep 03, 2026 | $12.78 | -55.39% | $7.84 | -34.45% | -20.94% |
| Sep 02, 2026 | $9.75 | -65.97% | $7.35 | -38.55% | -27.42% |
| Sep 01, 2026 | $6.59 | -77.00% | $6.80 | -43.14% | -33.86% |
| Aug 31, 2026 | $4.56 | -84.08% | $6.39 | -46.57% | -37.51% |
| Aug 28, 2026 | $4.87 | -83.00% | $6.09 | -49.08% | -33.92% |
| Aug 27, 2026 | $5.06 | -82.34% | $6.04 | -49.54% | -32.80% |
| Aug 26, 2026 | $5.09 | -82.23% | $5.83 | -51.25% | -30.98% |
| Aug 25, 2026 | $5.19 | -81.88% | $5.91 | -50.59% | -31.29% |
| Aug 24, 2026 | $5.82 | -79.69% | $5.89 | -50.75% | -28.94% |
| Aug 21, 2026 | $6.00 | -79.06% | $6.29 | -47.41% | -31.65% |
Page 1 of 9